Eslicarbazepine acetate 800 mg/1 (Eslicarbazepine acetate TABLET) 800 mg/1

Eslicarbazepine acetate 800 mg tablets are an anticonvulsant medication used to manage certain types of seizures. This oral medication is designed to help control epileptic activity in the brain, offering a reliable treatment option for those with epilepsy.

Strength

800 mg/1

Pack Size

500 TABLET in 1 BOTTLE (13668-541-05)

Manufacturer / TM Owner

Torrent Pharmaceuticals Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Eslicarbazepine acetate is primarily used as an adjunctive therapy for partial-onset seizures in adults with epilepsy. It works by stabilizing electrical activity in the brain, which can help reduce the frequency and severity of seizures. This medication is often prescribed when other treatments have not been fully effective.

Side Effects

Common effects of Eslicarbazepine acetate may include dizziness, nausea, and fatigue. Some users might experience headaches or blurred vision. These effects can vary from person to person and may diminish over time as the body adjusts to the medication.

Precautions & Warnings

Eslicarbazepine acetate should be handled with care, especially for those with a history of liver or kidney issues. It is important to follow the prescribed dosage and consult a healthcare provider before making any changes. Always store the medication in a cool, dry place away from direct sunlight.

Avoid Interactions

Eslicarbazepine acetate may interact with other medications, including certain antidepressants and anticonvulsants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided as it can exacerbate side effects.

Frequently Asked Questions

Eslicarbazepine acetate is used as an adjunctive treatment for partial-onset seizures in adults with epilepsy.

Eslicarbazepine acetate is taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects include dizziness, nausea, fatigue, headaches, and blurred vision.

Eslicarbazepine acetate may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Long-term use of Eslicarbazepine acetate should be monitored by a healthcare provider to ensure safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.